In the hopes of mitigating chemotherapy's side effects, scientists have explored delivery systems that target tumors more effectively. Among these researchers is Ninh (Irene) La-Beck, Pharm.D., from the Department of Immunotherapeutics and Biotechnology at Texas Tech University Health Sciences Center (TTUHSC) Jerry H. Hodge School of Pharmacy. La-Beck recently received a five-year, $2.
49 million grant ('Cholesterol Metabolism in the Pharmacology of Liposomal Therapeutics') from the National Cancer Institute at the National Institutes of Health. She says the grant allows her to investigate how nanoparticles interact with the immune system and cancer so that new drug delivery systems can be developed. Nanoparticles, approximately the size of a virus particle, show considerable promise in transporting drugs to tumors, presenting a potential solution to chemotherapy challenges
Source: Education Headlines (educationheadlines.net)
Texas Tech University Researcher Grant Nanoparticles Drug Delivery Immune System Cancer
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: MetroUK - 🏆 13. / 82 Read more »
Source: The Athletic UK - 🏆 123. / 51 Read more »
Source: The Athletic UK - 🏆 123. / 51 Read more »
Source: The Athletic UK - 🏆 123. / 51 Read more »
TTUHSC receives nearly $2.3 million in CPRIT grants to support cancer researchThe Cancer Prevention and Research Institute of Texas (CPRIT) recently awarded grants to four researchers from the Texas Tech University Health Sciences Center (TTUHSC).
Source: NewsMedical - 🏆 19. / 71 Read more »
Source: EchoWhatsOn - 🏆 74. / 59 Read more »